4.8 Article

ZRF1 is a novel S6 kinase substrate that drives the senescence programme

期刊

EMBO JOURNAL
卷 36, 期 6, 页码 736-750

出版社

WILEY
DOI: 10.15252/embj.201694966

关键词

mTOR; senescence; S6 kinase; tuberous sclerosis complex; ZRF1

资金

  1. European Research Council
  2. Fondation Schlumberger pour I'Education et la Recherche, Agence Nationale de la Recherche
  3. Association Sclerose Tubereuse de Bourneville
  4. Inserm AgeMed transversal program
  5. Institut National du Cancer

向作者/读者索取更多资源

The inactivation of S6 kinases mimics several aspects of caloric restriction, including small body size, increased insulin sensitivity and longevity. However, the impact of S6 kinase activity on cellular senescence remains to be established. Here, we show that the constitutive activation of mammalian target of rapamycin complex 1 (mTORC1) by tuberous sclerosis complex (TSC) mutations induces a premature senescence programme in fibroblasts that relies on S6 kinases. To determine novel molecular targets linking S6 kinase activation to the control of senescence, we set up a chemical genetic screen, leading to the identification of the nuclear epigenetic factor ZRF1 (also known as DNAJC2, MIDA1, Mpp11). S6 kinases phosphorylate ZRF1 on Ser47 in cultured cells and in mammalian tissues in vivo. Knockdown of ZRF1 or expression of a phosphorylation mutant is sufficient to blunt the S6 kinasedependent senescence programme. This is traced by a sharp alteration in p16 levels, the cell cycle inhibitor and a master regulator of senescence. Our findings reveal a mechanism by which nutrient sensing pathways impact on cell senescence through the activation of mTORC1S6 kinases and the phosphorylation of ZRF1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据